Odilorhabdin NOSO-95179
| Internal ID | f7dc4e4b-4642-44c0-a875-b5b1b6e98f76 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | (Z)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2R)-5-amino-2-[[2-[[(2S)-2-[[(2S,3S)-4-amino-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]acetyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pent-2-enoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C43H76N18O11/c1-24(55-40(69)34(32(62)20-47)60-36(65)26(48)9-2-4-14-44)35(64)53-22-33(63)56-28(11-6-16-46)41(70)61-18-8-13-31(61)39(68)59-30(19-25-21-51-23-54-25)38(67)57-27(10-3-5-15-45)37(66)58-29(42(71)72)12-7-17-52-43(49)50/h12,21,23-24,26-28,30-32,34,62H,2-11,13-20,22,44-48H2,1H3,(H,51,54)(H,53,64)(H,55,69)(H,56,63)(H,57,67)(H,58,66)(H,59,68)(H,60,65)(H,71,72)(H4,49,50,52)/b29-12-/t24-,26-,27-,28+,30-,31-,32-,34-/m0/s1 |
| InChI Key | VQUGHNAKLLLLKI-YKEDTOGJSA-N |
| Popularity | 4 references in papers |
| Molecular Formula | C43H76N18O11 |
| Molecular Weight | 1021.20 g/mol |
| Exact Mass | 1020.59409531 g/mol |
| Topological Polar Surface Area (TPSA) | 505.00 Ų |
| XlogP | -9.50 |
| Atomic LogP (AlogP) | -7.10 |
| H-Bond Acceptor | 17 |
| H-Bond Donor | 17 |
| Rotatable Bonds | 34 |
| (Z)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-1-[(2R)-5-amino-2-[[2-[[(2S)-2-[[(2S,3S)-4-amino-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxybutanoyl]amino]propanoyl]amino]acetyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]hexanoyl]amino]-5-(diaminomethylideneamino)pent-2-enoic acid |
| (Z)-2-(((2S)-6-amino-2-(((2S)-2-(((2S)-1-((2R)-5-amino-2-((2-(((2S)-2-(((2S,3S)-4-amino-2-(((2S)-2,6-diaminohexanoyl)amino)-3-hydroxybutanoyl)amino)propanoyl)amino)acetyl)amino)pentanoyl)pyrrolidine-2-carbonyl)amino)-3-(1H-imidazol-5-yl)propanoyl)amino)hexanoyl)amino)-5-(diaminomethylideneamino)pent-2-enoic acid |
| RefChem:167931 |
| (2Z)-2-(((2S)-6-amino-2-(((2S)-2-((((2S)-1-((2R)-5-amino-2-((2-(((2S)-2-(((2S,3S)-4-amino-2-(((2S)-2,6-diamino-1-hydroxyhexylidene)amino)-1,3-dihydroxybutylidene)amino)-1-hydroxypropylidene)amino)-1-hydroxyethylidene)amino)pentanoyl)pyrrolidin-2-yl)(hydroxy)methylidene)amino)-1-hydroxy-3-(1H-imidazol-5-yl)propylidene)amino)-1-hydroxyhexylidene)amino)-5-carbamimidamidopent-2-enoate |
| (2Z)-2-{[(2S)-6-amino-2-{[(2S)-2-({[(2S)-1-[(2R)-5-amino-2-[(2-{[(2S)-2-{[(2S,3S)-4-amino-2-{[(2S)-2,6-diamino-1-hydroxyhexylidene]amino}-1,3-dihydroxybutylidene]amino}-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]pentanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-3-(1H-imidazol-5-yl)propylidene]amino}-1-hydroxyhexylidene]amino}-5-carbamimidamidopent-2-enoate |
| CHEMBL4174689 |
| SCHEMBL17642044 |
| CHEBI:218854 |
| BDBM611551 |
| US10626144, Compound 24.66 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.5733 | 57.33% |
| Caco-2 | - | 0.8626 | 86.26% |
| Blood Brain Barrier | - | 0.7500 | 75.00% |
| Human oral bioavailability | - | 0.5857 | 58.57% |
| Subcellular localzation | Mitochondria | 0.7091 | 70.91% |
| OATP2B1 inhibitior | - | 0.8587 | 85.87% |
| OATP1B1 inhibitior | + | 0.7980 | 79.80% |
| OATP1B3 inhibitior | + | 0.9339 | 93.39% |
| MATE1 inhibitior | - | 0.8009 | 80.09% |
| OCT2 inhibitior | - | 0.7000 | 70.00% |
| BSEP inhibitior | + | 0.9754 | 97.54% |
| P-glycoprotein inhibitior | + | 0.7437 | 74.37% |
| P-glycoprotein substrate | + | 0.8538 | 85.38% |
| CYP3A4 substrate | + | 0.7302 | 73.02% |
| CYP2C9 substrate | - | 0.8039 | 80.39% |
| CYP2D6 substrate | - | 0.8340 | 83.40% |
| CYP3A4 inhibition | - | 0.8924 | 89.24% |
| CYP2C9 inhibition | - | 0.8562 | 85.62% |
| CYP2C19 inhibition | - | 0.8100 | 81.00% |
| CYP2D6 inhibition | - | 0.9032 | 90.32% |
| CYP1A2 inhibition | - | 0.7934 | 79.34% |
| CYP2C8 inhibition | + | 0.7600 | 76.00% |
| CYP inhibitory promiscuity | - | 0.9664 | 96.64% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.9100 | 91.00% |
| Carcinogenicity (trinary) | Non-required | 0.5447 | 54.47% |
| Eye corrosion | - | 0.9851 | 98.51% |
| Eye irritation | - | 0.8982 | 89.82% |
| Skin irritation | - | 0.7535 | 75.35% |
| Skin corrosion | - | 0.9186 | 91.86% |
| Ames mutagenesis | - | 0.5454 | 54.54% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.4257 | 42.57% |
| Micronuclear | + | 0.8100 | 81.00% |
| Hepatotoxicity | - | 0.6091 | 60.91% |
| skin sensitisation | - | 0.8414 | 84.14% |
| Respiratory toxicity | + | 0.8667 | 86.67% |
| Reproductive toxicity | + | 0.9444 | 94.44% |
| Mitochondrial toxicity | + | 0.8250 | 82.50% |
| Nephrotoxicity | - | 0.8564 | 85.64% |
| Acute Oral Toxicity (c) | III | 0.5968 | 59.68% |
| Estrogen receptor binding | + | 0.7412 | 74.12% |
| Androgen receptor binding | + | 0.6505 | 65.05% |
| Thyroid receptor binding | + | 0.5607 | 56.07% |
| Glucocorticoid receptor binding | - | 0.4705 | 47.05% |
| Aromatase binding | + | 0.6918 | 69.18% |
| PPAR gamma | + | 0.6557 | 65.57% |
| Honey bee toxicity | - | 0.7287 | 72.87% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.5600 | 56.00% |
| Fish aquatic toxicity | - | 0.5428 | 54.28% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.89% | 89.63% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.78% | 98.95% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.63% | 96.09% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.63% | 98.33% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 98.96% | 100.00% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 97.88% | 93.10% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 97.36% | 97.23% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.98% | 97.09% |
| CHEMBL236 | P41143 | Delta opioid receptor | 96.67% | 99.35% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 96.19% | 91.11% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 96.17% | 97.64% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 95.97% | 96.67% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 95.73% | 88.42% |
| CHEMBL3837 | P07711 | Cathepsin L | 95.68% | 96.61% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 95.43% | 98.10% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 95.20% | 90.20% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 95.00% | 98.24% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 94.54% | 93.33% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 94.43% | 98.94% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 94.01% | 94.45% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 93.59% | 93.56% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 93.44% | 100.00% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 93.39% | 99.17% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 93.33% | 100.00% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 93.26% | 82.69% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 93.14% | 96.00% |
| CHEMBL1907589 | P17787 | Neuronal acetylcholine receptor; alpha4/beta2 | 93.01% | 94.55% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 92.43% | 90.71% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 92.36% | 96.67% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 92.22% | 95.52% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 92.10% | 97.21% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 91.98% | 95.58% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 91.55% | 95.89% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 91.39% | 96.90% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 91.30% | 96.28% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 91.15% | 93.03% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 90.32% | 93.18% |
| CHEMBL3038469 | P24941 | CDK2/Cyclin A | 90.06% | 91.38% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 89.86% | 93.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 89.10% | 99.17% |
| CHEMBL233 | P35372 | Mu opioid receptor | 88.76% | 97.93% |
| CHEMBL2535 | P11166 | Glucose transporter | 88.64% | 98.75% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 88.52% | 88.56% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 88.12% | 82.86% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 87.49% | 96.47% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 87.43% | 98.05% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 86.61% | 90.24% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 86.19% | 95.56% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 85.71% | 95.00% |
| CHEMBL1907603 | Q05586 | Glutamate NMDA receptor; GRIN1/GRIN2B | 85.04% | 95.89% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 84.42% | 92.38% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 84.39% | 90.08% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 84.04% | 94.66% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 82.43% | 98.89% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 82.36% | 82.38% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 82.30% | 96.03% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 82.16% | 95.50% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 82.15% | 97.50% |
| CHEMBL3746 | P80365 | 11-beta-hydroxysteroid dehydrogenase 2 | 81.95% | 94.78% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 81.90% | 90.17% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 81.86% | 94.00% |
| CHEMBL204 | P00734 | Thrombin | 81.67% | 96.01% |
| CHEMBL2885 | P07451 | Carbonic anhydrase III | 81.58% | 87.45% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 80.96% | 82.50% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 80.71% | 91.19% |
| CHEMBL5028 | O14672 | ADAM10 | 80.06% | 97.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 121246409 |
| LOTUS | LTS0273498 |
| wikiData | Q105291505 |